Home > Insider Trading > Filing (0001209191-14-038324)

Filing Details

Accession Number:: 0001209191-14-038324
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-06-02 16:11:15
Reporting Period:: 2014-05-29

Filing Date:: 2014-06-02
Accepted Time:: 2014-06-02 16:11:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1593034	Endo International Plc	ENDP	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1179357	B Caroline Manogue	C/O Endo International Plc 33 Fitzwilliam Square Dublin L2 2	Exec. V.p., Clo & Secy	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Acquisiton	2014-05-29	42,279	$30.55	76,842	No	4	M	Direct
Ordinary Shares	Acquisiton	2014-05-29	50,000	$24.87	126,842	No	4	M	Direct
Ordinary Shares	Acquisiton	2014-05-29	40,722	$25.19	167,564	No	4	M	Direct
Ordinary Shares	Acquisiton	2014-05-29	42,032	$19.93	209,596	No	4	M	Direct
Ordinary Shares	Disposition	2014-05-29	175,033	$72.02	34,563	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	2004 Stock Incentive Plan Stock Options (NQ)	Disposition	2014-05-29	42,279	$0.00	42,279	$30.55
Ordinary Shares	2007 Stock Incentive Plan Stock Options (NQ)	Disposition	2014-05-29	50,000	$0.00	50,000	$24.87
Ordinary Shares	2007 Stock Incentive Plan Stock Options (NQ)	Disposition	2014-05-29	40,722	$0.00	40,722	$25.19
Ordinary Shares	2007 Stock Incentive Plan Stock Options (NQ)	Disposition	2014-05-29	42,032	$0.00	42,032	$19.93

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2017-02-21	No	4	M	Direct
0	2018-01-25	No	4	M	Direct
0	2018-02-21	No	4	M	Direct
42,033	2019-02-26	No	4	M	Direct

Footnotes

On March 10, 2014, in connection with her personal financial planning, Ms. Manogue placed 175,033 of the shares underlying her stock options into a 10b5-1 pre-set selling program (as amended, the "Manogue Pre-Set Selling Program"). The options exercised and the shares sold above were sold pursuant to the Manogue Pre-Set Selling Program, which leaves no remaining shares (underlying options) in the current Manogue Pre-Set Selling Program.
This represents the average price at which Ms. Manogue's ordinary shares were sold on May 29, 2014.
Ms. Manogue's stock options that were granted under the 2004 Stock Incentive Plan on February 21, 2007 were generally exercisable 25% per year on each of February 21, 2008, February 21, 2009, February 21, 2010, and February 21, 2011.
These securities were granted to Ms. Manogue in consideration of her services as the Executive Vice President, Chief Legal Officer and Secretary of Endo Health Solutions Inc.
Ms. Manogue's stock options that were granted under the 2007 Stock Incentive Plan on January 25, 2008 were generally exercisable 50% per year on each of January 25, 2009 and January 25, 2010.
Ms. Manogue's stock options that were granted under the 2007 Stock Incentive Plan on February 21, 2008 were generally exercisable 25% per year on each of February 21, 2009, February 21, 2010, February 21, 2011, and February 21, 2012.
Ms. Manogue's stock options that were granted under the 2007 Stock Incentive Plan on February 26, 2009 were generally exercisable 25% per year on each of February 26, 2010, February 26, 2011, February 26, 2012, and February 26, 2013.